Written Question·Department of Health and Social Care·UIN 62774

Alzheimer's Disease: Drugs

Tabled: 25 June 2025

Answered: 3 July 2025

Question

Mr Andrew Snowden

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 25 June to Question 61301 on Alzheimer's Disease: Drugs, whether NICE has made an assessment of the potential impact of not publishing the economic models for (a) lecanema

Answer

Karin Smyth

The National Institute for Health and Care Excellence’s (NICE) single technology appraisal process relies on information provided by companies to evaluate the clinical and cost-effectiveness of new treatments. Some of this information, including the econo...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 62774) →